Literature DB >> 1327523

Mutation of p53 gene in hepatocellular carcinoma in Taiwan.

J C Sheu1, G T Huang, P H Lee, J C Chung, H C Chou, M Y Lai, J T Wang, H S Lee, L N Shih, P M Yang.   

Abstract

To elucidate the role of p53 mutation in hepatocarcinogenesis in Taiwan, a hepatitis B viral infection hyperendemic area, exons 5 to 8 of the p53 gene in the tumor tissue of 61 hepatocellular carcinomas were amplified and sequenced. A total of 20 cases (32.8%) were found to have mutations; 36.6% (15 of 41) for the hepatitis B surface antigen positive group and 25.0% (5 of 20) for the hepatitis B surface antigen negative group. The corresponding normal liver showed no mutation. The mutation is widely distributed throughout exons 5 to 8. Only 4 cases (6.6%), all positive for hepatitis B surface antigen, had a specific hot spot mutation at codon 249 with G to T transversion. Our results show that scattered point mutations in p53 are not uncommon in hepatocellular carcinoma samples from Taiwan and may be important in the development of this cancer. However, the aflatoxin related specific mutation seems much less related to the genesis of hepatocellular carcinoma in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327523

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.

Authors:  Teodora A Todorova; Stanislav H Jordanov; Gergana S Stancheva; Ivan J Chalakov; Mincho B Melnicharov; Kuncho V Kunev; Vanio I Mitev; Radka P Kaneva; Teodora E Goranova
Journal:  Pathol Oncol Res       Date:  2014-08-23       Impact factor: 3.201

3.  An increased standardised mortality ratio for liver cancer among polyvinyl chloride workers in Taiwan.

Authors:  R-H Wong; P-C Chen; C-L Du; J-D Wang; T-J Cheng
Journal:  Occup Environ Med       Date:  2002-06       Impact factor: 4.402

4.  Genetic heterogeneity of hepatocellular carcinoma.

Authors:  H Unsal; C Yakicier; C Marçais; M Kew; M Volkmann; H Zentgraf; K J Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Authors:  K A McGlynn; E A Rosvold; E D Lustbader; Y Hu; M L Clapper; T Zhou; C P Wild; X L Xia; A Baffoe-Bonnie; D Ofori-Adjei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

6.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma?

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Ju-Yann Wu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 8.  Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?

Authors:  T Lasky; L Magder
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

9.  Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.

Authors:  C Y Shi; T W Phang; Y Lin; A Wee; B Li; H P Lee; C N Ong
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

10.  CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection.

Authors:  Chau-Ting Yeh; Chia-Jung Kuo; Ming-Wei Lai; Tse-Ching Chen; Chun-Yen Lin; Ta-Sen Yeh; Wei-Chen Lee
Journal:  BMC Cancer       Date:  2009-09-11       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.